Home › Mieloma multiplo › Connecticut › New Haven
Studi clinici su Mieloma multiplo a New Haven, CT
14 studi su Mieloma multiplo cercano partecipanti presso sedi a New Haven e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
In reclutamentoFase 3
- Research Site, New Haven
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
In reclutamentoFase 2
- Yale University School Of Medicine, New Haven
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 3
- Yale Cancer Center, New Haven
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
In reclutamentoFase 3
- Yale New Haven Hospital, New Haven
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 1
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi di distanza
- Smilow Cancer Hospital-Derby Care Center, Derby · a 8 mi di distanza
- e altri 1
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
In reclutamentoFase 1/2
- Smilow Cancer Center At Yale-New Haven /ID# 272447, New Haven
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
In reclutamentoFase 3
- Yale University, New Haven
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
In reclutamentoFase 1/2
- Yale New Haven Hospital-Smilow Cancer Center, New Haven
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
In reclutamentoFase 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · a 5 mi di distanza
- e altri 3
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
In reclutamentoFase 3
- Research Site, New Haven
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
In reclutamentoFase 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi di distanza
- e altri 2
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
In reclutamentoFase 3
- Yale New Haven Hospital, New Haven
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
In reclutamentoFase 2
- Yale University, New Haven
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
In reclutamentoFase 1
- Yale Cancer Center, New Haven
Studi su Mieloma multiplo in altre città
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Altri studi a New Haven
- Cancro del polmone non a piccole cellule41 studi
- Cancro al seno37 studi
- Cancro (tutti i tipi)33 studi
- Cancro metastatico23 studi
- Cancro ai polmoni22 studi
- Carcinoma a cellule squamose della testa e del collo22 studi
- Cancro ovarico21 studi
- Cancro colorettale20 studi
- Cancro alla prostata20 studi
- Overdose di oppioidi18 studi
- Disturbo da uso di alcol (AUD)17 studi
- Leucemia mieloide acuta17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.